The 64 rating InvestorsObserver gives to Aurinia Pharmaceuticals Inc (AUPH) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 83 percent of stocks in the Biotechnology industry, AUPH’s 64 overall rating means the stock scores better than 64 percent of all stocks.
AUPH has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on AUPH!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Aurinia Pharmaceuticals Inc Stock Today?
Aurinia Pharmaceuticals Inc (AUPH) stock is higher by 1.4% while the S&P 500 is lower by -0.19% as of 1:03 PM on Thursday, Nov 30. AUPH is up $0.12 from the previous closing price of $8.60 on volume of 1,166,125 shares. Over the past year the S&P 500 has risen 11.31% while AUPH is up 69.98%. AUPH lost -$0.54 per share the over the last 12 months.
Click Here to get the full Stock Report for Aurinia Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
